Bupropion Bupropion is an atypical antidepressant and smoking‑cessation aid that functions primarily as a norepinephrine‑dopamine reuptake inhibitor (NDRI). It is distinct from serotonin‑modulating agents, making it a useful alternative for patients who are intolerant of SSRIs or exhibit inadequate response. Mechanism of Action NDRI Activity: Inhibits the presynaptic transporters NET and DAT, increasing extracellular concentrations … Read more
Buprenorphine Buprenorphine is a semi‑synthetic, high‑affinity partial agonist at the μ‑opioid receptor (MOR) used for both acute and chronic pain management as well as opioid use disorder (OUD) treatment. Its unique pharmacology—high potency, ceiling effect for respiratory depression, and long duration—makes it a cornerstone of modern opioid stewardship. — Mechanism of Action Partial agonism at … Read more
Buprenex Buprenex (generic buprenorphine) is a semi‑synthetic opioid often used for chronic pain management and opioid dependence treatment. It is a partial agonist at the μ‑opioid receptor with antagonistic activity at κ and δ sites, offering a favorable safety profile and a modest ceiling effect on respiratory depression. Mechanism of Action Partial μ‑opioid receptor agonism … Read more
Bupivacaine Bupivacaine is a long‑acting amide‑type local anaesthetic widely used for peripheral, epidural, and spinal anaesthesia. It offers profound analgesia with a relatively low risk of systemic toxicity when used within safe dosage limits. Mechanism of Action Nav channel blockade: Bupivacaine preferentially binds to the closed‑state of voltage‑gated sodium channels (Nav1.7–1.9) in neuronal membranes, stabilizing … Read more
Bunavail Bunavail is a fixed-dose combination of buprenorphine (a partial μ‑opioid receptor agonist) and naloxone (an opioid antagonist). Indicated for the treatment of opioid dependence and for the management of opioid withdrawal symptoms in adults. Mechanism of Action Buprenorphine: Partial agonist at the μ‑opioid receptor → provides analgesia and reduces withdrawal. High receptor affinity and … Read more
Bumex Bumex is the brand name for bumetanide, a potent loop diuretic used in the management of fluid overload. — Mechanism of Action Inhibits the Na⁺‑K⁺‑2Cl⁻ cotransporter (NKCC2) in the thick ascending limb of the loop of Henle. Blocks reabsorption of Na⁺, K⁺, and Cl⁻, leading to osmotic diuresis and natriuresis. Decreases the reabsorption of … Read more
Bumetanide Bumetanide is a potent loop diuretic used for volume overload and edema in various clinical settings. It acts on the Na⁺‑K⁺‑2Cl⁻ symporter in the thick ascending limb of the loop of Henle, producing profound natriuresis and diuresis. Mechanism of Action Inhibition of the Na⁺‑K⁺‑2Cl⁻ symporter in the thick ascending limb → ↓ Na⁺, K⁺, … Read more
Budesonide Budesonide is a potent, lipophilic inhaled corticosteroid used for the treatment and prevention of airway inflammation in asthma and COPD, as well as for mucosal inflammation in gastrointestinal disorders such as ulcerative colitis, Crohn’s disease, and irritable bowel syndrome with diarrhea (IBS‑D). Mechanism of Action Glucocorticoid receptor (GR) activation: Binds intracellular GR, translocates to … Read more
I’m not aware of any medication named Bryhali in the current scientific or clinical literature. Because the drug is not recognized, I can’t provide reliable pharmacologic details. If you’re looking for information on a specific medication, double‑check the spelling or consult up‑to‑date references such as drug formularies, FDA labeling, or peer‑reviewed journals. Post Views: 0
Brukinsa Brukinsa (ibrutinib) is an orally administered, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor indicated for several B‑cell malignancies. Mechanism of Action Irreversible covalent inhibition of BTK at Cys‑481, blocking B‑cell receptor signaling. Leads to apoptosis, impaired migration, and decreased proliferation of malignant B‑cells. Also exhibits off‑target inhibition of EGFR, VEGFR, ITK, and TEC family kinases, … Read more